Evidence map›Paper›PMID 41852899›Full record

ArticleOncology letters2026

Malignant mesothelioma of the tunica vaginalis testis: A case report.

Yuanchen Lu, Junjun Miu, Zhongru Fan, Zheng Zhi, Lei He, Junpeng Deng, Xianhua Shao, Jingqi Hua, Yichen Qian, Jianjun Xie

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuanchen LuDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Junjun MiuDepartment of Pathology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Zhongru FanDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Zheng ZhiDepartment of Pathology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Lei HeDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Junpeng DengDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Xianhua ShaoDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Jingqi HuaDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Yichen QianDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.
Jianjun XieDepartment of Urology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant mesothelioma of the tunica vaginalis testis (MMTVT) is a rare pathological entity. The present report describes the case of a patient who presented with insidious-onset right lower abdominal pain and was diagnosed via histopathological examination following a radical right orchidectomy. After 7 months, the patient developed a palpable mass along the spermatic cord, which prompted a laparoscopic retroperitoneal lymph node dissection combined with an inguinal tumor resection. Adjuvant chemotherapy with pemetrexed and cisplatin was administered thereafter. At 9 months after the initial surgery, a groin mass was surgically excised, with pathology revealing fibroinflammatory changes. The patient remained under close surveillance without evidence of recurrence. Radiation therapy was initiated at 13 months post-surgery but was temporarily discontinued due to adverse effects. Given the current absence of standardized treatment guidelines for MMTVT, radical surgical resection combined with adjuvant radiotherapy or chemotherapy remains the mainstay of therapy, with the inguinal approach being the most commonly employed technique. Given the validated efficacy of immunotherapy in certain rare diseases and pleural mesothelioma, it may represent a promising therapeutic alternative for MMTVT patients whose pathological immunohistochemistry meets eligibility criteria and who have failed standard adjuvant radiotherapy and chemotherapy.

Indexed as

immunotherapymalignant mesothelioma of the tunica vaginalis testisradical surgical resection

Identifiers

PMID41852899
PMCPMC12994138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.